Video: US FDA on strategies to address unmet #RareDisease patient needs

In Uncategorized by Caroline Hornby

Timothy Cote and fda on rare disease access Dr. Timothy Cote, Director of the Office of Orphan Product Development at the US FDA, presented at last year’s World Orphan Drug Congress USA on the topic ‘Building an integrated, comprehensive and long-term strategy to address unmet patient needs in the US.’

Do you want to learn more about:

  • Incentives to make orphan diseases a national priority
  • Brownback/Brown Amendment status update
  • Industry role in supporting product development
  • Integrating industry, government and patient organization efforts

If so, you need to check out the video below:

For more information on orphan drugs and rare diseases, check out the World Orphan Drug Congress USA. Remember, the earlier you book, the more you save, so register now to secure your seat!